GenixPharmaceucticals Corporation (GENX) — Cash Flow Reinvestment Rate

Latest as of April 2020: 9.91x

GenixPharmaceucticals Corporation (GENX) has a Cash Flow Reinvestment Rate of 9.91x as of April 2020, reinvesting CA$1.26 Million (capex CA$0.00 plus investments CA$-1.26 Million) from operating cash flow of CA$126.87K. See GenixPharmaceucticals Corporation free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

9.91x
(Capex + Investments) / Operating CF

Total Reinvested

CA$1.26 Million
Capex + Investments

Operating Cash Flow

CA$126.87K
CAD

Capital Expenditures

CA$0.00
CAD

GenixPharmaceucticals Corporation Cash Flow Reinvestment Rate (2018–2018)

Historical reinvestment intensity for GenixPharmaceucticals Corporation across 1 annual periods. For the full cash flow conversion analysis, see GENX operating cash flow.

Annual Cash Flow Reinvestment Rate for GenixPharmaceucticals Corporation (2018–2018)

Year-by-year capital reinvestment analysis for GenixPharmaceucticals Corporation. See GENX free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.

Year Reinvestment Rate Total Reinvested (CAD) Operating CF Capex YoY Change
2018 1.91x CA$65.34K CA$34.18K CA$0.00 —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow